Evidence map›Paper›PMID 41994456›Full record

ArticleFrontiers in medicine2026

Lung allograft injury improves after gastroesophageal reflux surgery by donor-derived cell-free DNA kinetics.

Samir Sultan, Jon C Gould, Andrew S Kastenmeier, Gokulakrishnan Balasubramanian, Niraja Suresh, David J Ross

Abstract read
In one paragraph

Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Samir SultanMedical College of Wisconsin, Milwaukee, WI, United States.
Jon C GouldMedical College of Wisconsin, Milwaukee, WI, United States.
Andrew S KastenmeierMedical College of Wisconsin, Milwaukee, WI, United States.
Gokulakrishnan BalasubramanianMedical College of Wisconsin, Milwaukee, WI, United States.
Niraja SureshNatera Inc., Austin, TX, United States.
David J RossNatera Inc., Austin, TX, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gastroesophageal reflux disease (GERD) and bile acid micro-aspiration are risk factors for the development of chronic lung allograft dysfunction (CLAD) after lung transplantation (LT). Donor-derived cell-free DNA (dd-cfDNA) is a clinically validated plasma biomarker for acute rejection but also detects other types of allograft injury and can potentially be used to detect GERD and micro-aspiration. Here, we report a five-case single-center series of LT patients with confirmed GERD and micro-aspiration, treated by Toupet fundoplication and adjunctive laparoscopic procedures. dd-cfDNA fraction measured pre

Indexed as

aspirationbiomarkercell-free DNAchronic lung allograft dysfunctiongastroesophageal refluxGERDlung transplantation

Identifiers

PMID41994456
PMCPMC13079314

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.